Insmed IncorporatedINSMNASDAQ
LOADING
|||
Net Income Growth Recovery in Progress
Trending higher, below historical average, modest growth trend.
Left:
||||
Year-over-year net income growth rate
Latest
-15.03%
↓ 55% below average
Average (39q)
-9.67%
Historical baseline
Range
High:45.30%
Low:-91.36%
CAGR
+7.4%
Consistent expansion
| Period | Value |
|---|---|
| Q3 2025 | -15.03% |
| Q2 2025 | -25.37% |
| Q1 2025 | -8.93% |
| Q4 2024 | -6.81% |
| Q3 2024 | 26.64% |
| Q2 2024 | -91.36% |
| Q1 2024 | 15.57% |
| Q4 2023 | -17.07% |
| Q3 2023 | 35.08% |
| Q2 2023 | -53.23% |
| Q1 2023 | 0.22% |
| Q4 2022 | -22.10% |
| Q3 2022 | -37.12% |
| Q2 2022 | -1.08% |
| Q1 2022 | 16.25% |
| Q4 2021 | -0.23% |
| Q3 2021 | 3.93% |
| Q2 2021 | -28.02% |
| Q1 2021 | 10.34% |
| Q4 2020 | -60.56% |
| Q3 2020 | -2.92% |
| Q2 2020 | 6.80% |
| Q1 2020 | -25.24% |
| Q4 2019 | 12.68% |
| Q3 2019 | 8.77% |
| Q2 2019 | 10.30% |
| Q1 2019 | 19.02% |
| Q4 2018 | -4.37% |
| Q3 2018 | -14.79% |
| Q2 2018 | -11.55% |
| Q1 2018 | -4.80% |
| Q4 2017 | -44.72% |
| Q3 2017 | -1.13% |
| Q2 2017 | -19.40% |
| Q1 2017 | 45.30% |
| Q4 2016 | -81.15% |
| Q3 2016 | -3.23% |
| Q2 2016 | -9.09% |
| Q1 2016 | -7.32% |
| Q4 2015 | -0.91% |